WeightWatchers, officially rebranded as WW International (NASDAQ:WW), has blamed its financial woes on the GLP-1 drug wave and the do-it-yourself (DIY) weight-loss approach popularized on social media.

“WeightWatchers’ holistic model of care—including its No. 1 doctor-recommended weight loss program, telehealth offering with access to obesity-trained clinicians and prescription weight-loss medications, and virtual and in-person workshops—remain fully operational during the reorganization process.”

WW got a brief reprieve from its troubles when it added GLP-1 weight loss treatments to its services, but noted that they are a “medication, not a miracle.”